Cargando…
Author Correction: Liposomal formulation of Galbanic acid improved therapeutic efficacy of pegylated liposomal Doxorubicin in mouse colon carcinoma
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7044310/ https://www.ncbi.nlm.nih.gov/pubmed/32103120 http://dx.doi.org/10.1038/s41598-020-60918-2 |
| _version_ | 1783501543016759296 |
|---|---|
| author | Nik, Maryam Ebrahimi Malaekeh-Nikouei, Bizhan Amin, Mohamadreza Hatamipour, Mahdi Teymouri, Manouchehr Sadeghnia, Hamid Reza Iranshahi, Mehrdad Jaafari, Mahmoud Reza |
| author_facet | Nik, Maryam Ebrahimi Malaekeh-Nikouei, Bizhan Amin, Mohamadreza Hatamipour, Mahdi Teymouri, Manouchehr Sadeghnia, Hamid Reza Iranshahi, Mehrdad Jaafari, Mahmoud Reza |
| author_sort | Nik, Maryam Ebrahimi |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7044310 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Nature Publishing Group UK |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-70443102020-03-04 Author Correction: Liposomal formulation of Galbanic acid improved therapeutic efficacy of pegylated liposomal Doxorubicin in mouse colon carcinoma Nik, Maryam Ebrahimi Malaekeh-Nikouei, Bizhan Amin, Mohamadreza Hatamipour, Mahdi Teymouri, Manouchehr Sadeghnia, Hamid Reza Iranshahi, Mehrdad Jaafari, Mahmoud Reza Sci Rep Author Correction Nature Publishing Group UK 2020-02-27 /pmc/articles/PMC7044310/ /pubmed/32103120 http://dx.doi.org/10.1038/s41598-020-60918-2 Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
| spellingShingle | Author Correction Nik, Maryam Ebrahimi Malaekeh-Nikouei, Bizhan Amin, Mohamadreza Hatamipour, Mahdi Teymouri, Manouchehr Sadeghnia, Hamid Reza Iranshahi, Mehrdad Jaafari, Mahmoud Reza Author Correction: Liposomal formulation of Galbanic acid improved therapeutic efficacy of pegylated liposomal Doxorubicin in mouse colon carcinoma |
| title | Author Correction: Liposomal formulation of Galbanic acid improved therapeutic efficacy of pegylated liposomal Doxorubicin in mouse colon carcinoma |
| title_full | Author Correction: Liposomal formulation of Galbanic acid improved therapeutic efficacy of pegylated liposomal Doxorubicin in mouse colon carcinoma |
| title_fullStr | Author Correction: Liposomal formulation of Galbanic acid improved therapeutic efficacy of pegylated liposomal Doxorubicin in mouse colon carcinoma |
| title_full_unstemmed | Author Correction: Liposomal formulation of Galbanic acid improved therapeutic efficacy of pegylated liposomal Doxorubicin in mouse colon carcinoma |
| title_short | Author Correction: Liposomal formulation of Galbanic acid improved therapeutic efficacy of pegylated liposomal Doxorubicin in mouse colon carcinoma |
| title_sort | author correction: liposomal formulation of galbanic acid improved therapeutic efficacy of pegylated liposomal doxorubicin in mouse colon carcinoma |
| topic | Author Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7044310/ https://www.ncbi.nlm.nih.gov/pubmed/32103120 http://dx.doi.org/10.1038/s41598-020-60918-2 |
| work_keys_str_mv | AT nikmaryamebrahimi authorcorrectionliposomalformulationofgalbanicacidimprovedtherapeuticefficacyofpegylatedliposomaldoxorubicininmousecoloncarcinoma AT malaekehnikoueibizhan authorcorrectionliposomalformulationofgalbanicacidimprovedtherapeuticefficacyofpegylatedliposomaldoxorubicininmousecoloncarcinoma AT aminmohamadreza authorcorrectionliposomalformulationofgalbanicacidimprovedtherapeuticefficacyofpegylatedliposomaldoxorubicininmousecoloncarcinoma AT hatamipourmahdi authorcorrectionliposomalformulationofgalbanicacidimprovedtherapeuticefficacyofpegylatedliposomaldoxorubicininmousecoloncarcinoma AT teymourimanouchehr authorcorrectionliposomalformulationofgalbanicacidimprovedtherapeuticefficacyofpegylatedliposomaldoxorubicininmousecoloncarcinoma AT sadeghniahamidreza authorcorrectionliposomalformulationofgalbanicacidimprovedtherapeuticefficacyofpegylatedliposomaldoxorubicininmousecoloncarcinoma AT iranshahimehrdad authorcorrectionliposomalformulationofgalbanicacidimprovedtherapeuticefficacyofpegylatedliposomaldoxorubicininmousecoloncarcinoma AT jaafarimahmoudreza authorcorrectionliposomalformulationofgalbanicacidimprovedtherapeuticefficacyofpegylatedliposomaldoxorubicininmousecoloncarcinoma |